Online inquiry

IVTScrip™ mRNA-Human ARHGAP21, (Cap 1, Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK27087MR)

This product GTTS-WK27087MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & Pseudo-UTP. It ecodes the ARHGAP21 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001367447.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 57584
UniProt ID Q5T5U3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP21, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK27087MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK11273MR IVTScrip™ mRNA-Human ACTR3B, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACTR3B
GTTS-WK28697MR IVTScrip™ mRNA-Human ASB16-AS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASB16-AS1
GTTS-WK12210MR IVTScrip™ mRNA-Human ADAP1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADAP1
GTTS-WK28695MR IVTScrip™ mRNA-Human ASB13, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASB13
GTTS-WK17006MR IVTScrip™ mRNA-Human ANKRD2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD2
GTTS-WK12830MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK6227MR IVTScrip™ mRNA-Human CD24, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CD24
GTTS-WK24149MR IVTScrip™ mRNA-Human ARL6IP5, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARL6IP5
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →